Global Biologic Therapy Market to Grow Healthily over 2023
Biologic therapy is gaining traction. According to a report
published by Market Research Future (MRFR), the global biologic therapy market size is set to reach USD 288.03 billion by 2030 at a CAGR 8.20%
over the forecast years 2023-2030. Biologic therapy is viewed as an innovative
treatment module based on products sourced from living organisms.
Biologic therapy is used to stimulate or suppress the immune
system for treatment purposes. The therapy finds application in treatment of
diseases such as infection, cancer and several other diseases. Advances in the
field of biologic therapeutic is boosting the application scope of biologic
therapy. Rising demand for biological and targeted drug therapies is making a
positive impact on the global biological therapy market. The R&D pipeline
for biologic therapy is expected to grow in the future as pharmaceutical
companies realise the vast market opportunities.
Global Biologic Therapy
Market: Competition Analysis
Global biologic therapy market players include
·
Amgen Inc.,
·
Eli Lilly,
·
Seattle Genetics, Inc.,
·
GlaxoSmithKline Plc.,
·
Novartis International
AG,
·
Celgene Corporation and
·
Spectrum
Pharmaceuticals, Inc.
Global Biologic Therapy
Market: Segmental Analysis
MRFR’s report includes a detailed segmental analysis of the
market based on therapy, product type, end-user and application. Based on
therapy, the market has been segmented into vaccines therapy, cell therapy,
protein therapy and others. Based on product type, the market has been
segmented into services, instruments and kit and reagents. Based on end-user,
the market has been segmented into hospitals and clinic, research centers and
speciality centers. Based on application, the market has been segmented into blood
and blood-related products testing, tissue and tissue-related products testing,
vaccine and therapeutics development, stem cell research and cellular and gene
therapy.
Global Biologic Therapy Market:
Regional Analysis
On the basis of region, the market has been segmented into
North America, Europe, the Middle East & Africa (MEA), Latin America and
Asia Pacific (APAC). North America represents an important market for biologic
therapy. Rising geriatric population, growing cancer prevalence in countries
such as the U.S. and Canada are some of the factors supporting the market
growth in the region. Data released by United States Census Bureau reveals that
the total count of Americans aged 65 and above surpassed 49.2
Mn in 2016. Advanced countries in North America have robust
health coverage policies along with a quicker access to latest biologic
therapeutics. Many market players operating in North America are focusing on
patient-centric products. In addition, companies are focusing on delivering
customized therapeutics. High healthcare spending in the region is also
influencing the market growth. The Center for Disease Control and Prevention
reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.
Europe in hold the second spot in the global biologic therapy
market in terms of revenue. The market in Europe is expected to exhibit a
healthy growth over the next couple of years. The healthcare sector remains
focused on innovation and continue to excel in delivering quality care. In
addition, presence of an advanced healthcare system is reflecting favourably on
the market in the region. Many of the advanced countries in Europe have large pool
of geriatric population. Data released by Eurostat revealed that more that 19%
of the over population in Europe is aged 65 and above.
Asia Pacific is emerging as a highly attractive market for
biologic therapy. It is projected that the market in APAC will demonstrate the
fastest growth during the forecast period. Increased occurrence of lifestyle
diseases is driving the demand for biologic therapy. Rising healthcare
expenditure, increased awareness level and improving healthcare infrastructure
are some of the key factors influencing the market in APAC.
The market in MEA is expected to witness a relatively slower
growth during the forecast period. This is mainly owing low penetration and
limited access. However, increased efforts towards improving healthcare
standard in GCC countries is likely to create market opportunities.
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
United
States of America
No comments:
Post a Comment